5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The France Aesthetic Medicine Market has been segmented by Product (Botulinum Toxin, Dermal Filler, Chemical Peel, and Microdermabrasion) and End User
The key factors propelling the growth of the market are the growing adoption of non-invasive aesthetic procedures, increasing awareness among customers, and availability of user-friendly aesthetic products.
In France, it has been observed that patients begin anti-ageing techniques and minimally invasive treatments at a very young age, and require more invasive procedures in order to maintain their youthful appearance. Moreover, the rise in disposable income has boosted the demand for cosmetic surgeries, thereby accelerating the market growth.
Along with the increased awareness about the potential benefits of aesthetic procedures, people are also inclined toward the use of minimal or non-invasive procedures in aesthetic treatments. The popularity of non-invasive or minimally invasive techniques is increasing in France. The reason for significant inclination is that the majority of the audiences perceive normal surgical treatments as painful and involved with a high risk factors. Thus, the growing adoption of non- or minimally invasive aesthetic procedures is fueling the growth of the medical aesthetic medicine market in France.
Additionally, there has also been an abundant rise in the advertising, displaying the ‘before’ and ‘after’ difference of various aesthetic procedures, thereby prompting the youth and middle aged to undergo medical aesthetic procedures.
As per the scope of the report, aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of ageing, infectious, or diseased skin conditions. Aesthetic medicines and cosmetic surgery is a developing clinical subspecialty and field in scientific research, which comprises all kind of medical procedures whose purpose is to improve the physical appearance and satisfaction of the patient, including all non-invasive and minimally invasive cosmetic procedures.
|By End User|
|Other End Users|
Report scope can be customized per your requirements. Click here.
The dermal filler segment has the largest market share, and is expected to continue during the forecast period. The dermal fillers segment is constantly developing in France, and accounts for a sales volume of around 850,000 dermal syringes annually. Absorbable dermal fillers are majorly contributing to the total dermal filler market segment in France, due to its less side effects. On the other hand, the agencies in France are currently not advising the use of non-absorbable products for aesthetic purpose, given the risk of extremely delayed, uncontrollable, and serious adverse effects.
To understand key trends, Download Sample Report
The French aesthetic medicine market is medium consolidated, with some local players competing with international players. The major strategies adopted by most of the key industry players include the new product launches, acquisitions, mergers, and partnerships to strengthen the aesthetics product portfolio and maintain their market position.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Adoption of Non- and Minimally Invasive Aesthetic Procedures
4.2.2 Increasing Awareness among Customers about Cosmetic Procedures
4.2.3 Availability of User-friendly Aesthetic Products
4.3 Market Restraints
4.3.1 Stringent Safety Regulations for Aesthetic Procedures
4.3.2 Risk of Side Effects
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Botulinum Toxin
5.1.2 Dermal Filler
126.96.36.199 Absorbable Dermal Filler
188.8.131.52 Non-absorbable Dermal Filler
5.1.3 Chemical Peel
5.2 By End User
5.2.1 Office Facilities
5.2.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 Bioxis Pharmaceuticals
6.1.3 Dermaceutic Laboratoire
6.1.4 Ipsen Pharma
6.1.5 Johnson & Johnson
6.1.6 Nestle Skin Health
6.1.7 Merz Pharma Gmbh & Co. Kgaa
6.1.8 Laboratoires Filorga
6.1.9 Teoxane Laboratories
6.1.10 Laboratories Vivacy
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments